Sign in

CIK 0001477449

  • Large accelerated filer

Teladoc Health, Inc.

Sign in to watch
Ticker
TDOC
Exchange
NYSE
Industry
Services-Offices & Clinics of Doctors of Medicine
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
043705970
Phone
+1 203-635-2002
Business address
155 E 44TH STREET, SUITE 1700, NEW YORK, NY, 10017
Former names
Teladoc, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$731,651
in 9 filings, $369K under 10b5-1 plans

Net −$731,651. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-09-04 Turitz Andrew EVP, CORPORATE DEVELOPMENT Sale 10b5-1 −20,773 $7.26 $151K 20,773
2024-09-03 Turitz Andrew EVP, CORPORATE DEVELOPMENT Sale −1,617 $7.16 $12K 41,546
2024-08-30 Turitz Andrew EVP, CORPORATE DEVELOPMENT Option exercise +1,056 38,715
2024-08-30 Turitz Andrew EVP, CORPORATE DEVELOPMENT Option exercise +1,348 40,063
2024-08-30 Turitz Andrew EVP, CORPORATE DEVELOPMENT Option exercise +3,100 43,163
2024-08-30 Turitz Andrew EVP, CORPORATE DEVELOPMENT Option exercise · Performance Stock Units −1,056 6,341
2024-08-30 Turitz Andrew EVP, CORPORATE DEVELOPMENT Option exercise · Restricted Stock Units −1,348 2,696
2024-08-30 Turitz Andrew EVP, CORPORATE DEVELOPMENT Option exercise · Restricted Stock Units −3,100 18,602
2024-06-03 Turitz Andrew EVP, CORPORATE DEVELOPMENT Sale −1,627 $11.16 $18K 37,659
2024-05-31 Turitz Andrew EVP, CORPORATE DEVELOPMENT Option exercise +1,056 34,838
2024-05-31 Turitz Andrew EVP, CORPORATE DEVELOPMENT Option exercise +1,348 36,186
2024-05-31 Turitz Andrew EVP, CORPORATE DEVELOPMENT Option exercise +3,100 39,286
2024-05-31 Turitz Andrew EVP, CORPORATE DEVELOPMENT Option exercise · Performance Stock Units −1,056 7,397
2024-05-31 Turitz Andrew EVP, CORPORATE DEVELOPMENT Option exercise · Restricted Stock Units −1,348 4,044
2024-05-31 Turitz Andrew EVP, CORPORATE DEVELOPMENT Option exercise · Restricted Stock Units −3,100 21,702
2024-03-19 Turitz Andrew EVP, CORPORATE DEVELOPMENT Grant or award · Restricted Stock Units +43,800 43,800
2024-03-05 Turitz Andrew EVP, CORPORATE DEVELOPMENT Sale 10b5-1 −5,647 $14.53 $82K 33,782
2024-03-04 Turitz Andrew EVP, CORPORATE DEVELOPMENT Sale 10b5-1 −6,190 $14.52 $90K 39,429
2024-03-01 Turitz Andrew EVP, CORPORATE DEVELOPMENT Sale 10b5-1 −475 $15.06 $7K 25,193
2024-03-01 Turitz Andrew EVP, CORPORATE DEVELOPMENT Option exercise 10b5-1 +4,226 29,419

Page 1 of 9 · 167 trades